Literature DB >> 12511529

Cerebral arteriolar structure in mice overexpressing human renin and angiotensinogen.

Gary L Baumbach1, Curt D Sigmund, Frank M Faraci.   

Abstract

We examined the hypothesis that the renin-angiotensin system plays an important role in vascular remodeling (defined as reduced external diameter) during chronic hypertension. We measured pressure, diameter, and cross-sectional area of the vessel wall in maximally dilated cerebral arterioles in transgenic mice that overexpress both human renin and human angiotensinogen and in spontaneously hypertensive mice, a model of chronic hypertension that is thought to develop independently of the renin-angiotensin system. Systemic arterial pressure under conscious conditions was increased by similar amounts in transgenically hypertensive mice (153+/-6 versus 117+/-4 mm Hg in controls; mean+/-SE, P<0.05) and spontaneously hypertensive mice (148+/-5 versus 112+/-5 mm Hg; P<0.05). The external diameter of maximally dilated cerebral arterioles was reduced in transgenically hypertensive mice (52+/-2 versus 66+/-3 micro m; P<0.05), but not in spontaneously hypertensive mice (58+/-4 versus 60+/-4 micro m; P>0.05). The cross-sectional area of the vessel wall was increased in both transgenically hypertensive mice (504+/-53 versus 379+/-37 microm2; P<0.05) and spontaneously hypertensive mice (488+/-40 versus 328+/-38 microm2; P<0.05). During maximal dilatation, the stress-strain curves in cerebral arterioles of transgenically hypertensive mice and spontaneously hypertensive mice were shifted to the right of the curves in corresponding controls, an indication that arteriolar distensibility was increased in the transgenically and spontaneously hypertensive groups. Thus, cerebral arterioles undergo remodeling and hypertrophy in transgenically hypertensive mice, but only hypertrophy in spontaneously hypertensive mice. These findings support the hypothesis that the renin-angiotensin system is an important determinant of vascular remodeling during chronic hypertension.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12511529     DOI: 10.1161/01.hyp.0000042427.05390.5c

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  42 in total

1.  Regional brain variations of cytochrome oxidase activity in spontaneously hypertensive mice.

Authors:  C Strazielle; R Lalonde; S Thifault; P Hamet
Journal:  Exp Brain Res       Date:  2004-03-06       Impact factor: 1.972

2.  Leaky vessels: how the brain deals with pregnancy under pressure.

Authors:  Frank M Faraci
Journal:  J Appl Physiol (1985)       Date:  2010-11-25

Review 3.  Ion channel networks in the control of cerebral blood flow.

Authors:  Thomas A Longden; David C Hill-Eubanks; Mark T Nelson
Journal:  J Cereb Blood Flow Metab       Date:  2015-11-09       Impact factor: 6.200

4.  Surviving the remodel: the impact of hypertension during pregnancy.

Authors:  Frank M Faraci
Journal:  Hypertension       Date:  2008-02-07       Impact factor: 10.190

Review 5.  Hypertension and cerebrovascular dysfunction.

Authors:  Costantino Iadecola; Robin L Davisson
Journal:  Cell Metab       Date:  2008-06       Impact factor: 27.287

6.  Potassium channelopathy-like defect underlies early-stage cerebrovascular dysfunction in a genetic model of small vessel disease.

Authors:  Fabrice Dabertrand; Christel Krøigaard; Adrian D Bonev; Emmanuel Cognat; Thomas Dalsgaard; Valérie Domenga-Denier; David C Hill-Eubanks; Joseph E Brayden; Anne Joutel; Mark T Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

Review 7.  Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke.

Authors:  Xiaoming Hu; T Michael De Silva; Jun Chen; Frank M Faraci
Journal:  Circ Res       Date:  2017-02-03       Impact factor: 17.367

Review 8.  Protecting against vascular disease in brain.

Authors:  Frank M Faraci
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-02-18       Impact factor: 4.733

9.  HB-EGF depolarizes hippocampal arterioles to restore myogenic tone in a genetic model of small vessel disease.

Authors:  Jackson T Fontaine; Amanda C Rosehart; Anne Joutel; Fabrice Dabertrand
Journal:  Mech Ageing Dev       Date:  2020-10-27       Impact factor: 5.432

10.  Interference with PPARgamma signaling causes cerebral vascular dysfunction, hypertrophy, and remodeling.

Authors:  Andreas M Beyer; Gary L Baumbach; Carmen M Halabi; Mary L Modrick; Cynthia M Lynch; Thomas D Gerhold; Shams M Ghoneim; Willem J de Lange; Henry L Keen; Yau-Sheng Tsai; Nobuyo Maeda; Curt D Sigmund; Frank M Faraci
Journal:  Hypertension       Date:  2008-02-19       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.